Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$560,019,596
-$80,712,886 QoQ
Shares Held
2,205,062
-15.9% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#90
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $2,905,699,167 across 10 Drug Manufacturers - General names. JNJ ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
734,148 | $880,559,208 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,205,062 | $560,019,596 | |
| 3 | ABBV |
AbbVie Inc.
|
1,904,997 | $479,373,444 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,913,536 | $245,889,375 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,759,349 | $222,276,152 | |
| 6 | AMGN |
Amgen Inc
|
578,474 | $209,477,004 | |
| 7 | PFE |
Pfizer Inc
|
7,718,545 | $185,862,562 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,794,030 | $103,372,007 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,019,596 | 2,205,062 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $640,732,482 | 2,621,226 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $469,510,154 | 2,268,713 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $412,106,704 | 2,222,558 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $309,686,571 | 2,027,408 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $328,347,278 | 1,979,904 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $405,896,565 | 2,806,642 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $479,637,798 | 2,959,631 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $471,390,553 | 3,225,168 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $554,645,935 | 3,506,201 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $578,831,257 | 3,692,939 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $620,758,289 | 3,985,607 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $706,557,871 | 4,268,716 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $626,432,190 | 4,041,498 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $672,523,860 | 3,807,098 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $561,515,529 | 3,437,289 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $631,534,958 | 3,557,743 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $725,118,642 | 4,091,399 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $742,956,837 | 4,342,999 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $756,486,994 | 4,684,130 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $806,013,842 | 4,892,642 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $692,954,656 | 4,216,335 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $543,800,929 | 3,455,337 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $1,409,893 | 9,470 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $1,460,723 | 10,387 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $1,226,852 | 9,356 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||